What Are the Benefits of Using Premixed IV Products?

Video
Conference|ASHP Summer

Dennis Killian, PharmD, PhD, Director of Pharmacy at Peninsula Regional Medical Center, talks about the benefits of using ready-to-use, premixed IV products versus compound IV products.

At the ASHP 2018 Summer Meeting and Exhibition, Dennis Killian, PharmD, PhD, Director of Pharmacy at Peninsula Regional Medical Center, sat down with Pharmacy Times to discuss the use of premixed IV products in comparison with compound IV products. In this clip, Dr. Killian talks about why premixed formulations should be considered and the benefits of these ready-to-use products.

Related Videos
Home Diabetes Treatment - Image credit: Dglimages | stock.adobe.com
Image credit: Azee/peopleimages.com | stock.adobe.com
Cropped view of senior man playing with puzzles on table- Image credit: LIGHTFIELD STUDIOS | stock.adobe.com
Breast cancer with lymphatics, medically 3D illustration | Image Credit: Axel Kock - stock.adobe.com
Woman with pink ribbon on color background. Breast cancer awareness concept | Image Credit: Pixel-Shot - stock.adobe.com
Pharmacy, medicine and senior woman consulting pharmacist on prescription. Healthcare, shopping and elderly female in consultation with medical worker for medication box, pills or product in store- Image credit: C Daniels/peopleimages.com | stock.adobe.com
View in microscopic of pathology cross section tissue ductal cell carcinoma or adenocarcinoma diagnosis by pathologist in laboratory | Image Credit: arcyto - stock.adobe.com
A female doctor sits at her desk and talks to a female patient while looking at her mammogram | Image Credit: lordn - stock.adobe.com
Doctor holding a digital tablet with x-ray of brain and skull skeleton. Headache, meningitis and migraine concept - Image credit: Steph photographies | stock.adobe.com
Related Content
Women with cancer receiving treatment

No Significant Differences at 5 Year Follow-Up Between Palbociclib-Based Treatment Regimens

December 8th 2023
Article
Pharmacy Focus: Conversations On Reproductive Health - Episode 2

Pharmacy Focus: Conversations On Reproductive Health - Episode 2

November 29th 2023
Podcast
The Future of Immunotherapy in Breast Cancer Involves Engineered T-Cell Therapies, Better Prediction of Adverse Effects

The Future of Immunotherapy in Breast Cancer Involves Engineered T-Cell Therapies, Better Prediction of Adverse Effects

December 8th 2023
Article
Pharmacy Focus: Conversations On Reproductive Health - Episode 1

Pharmacy Focus: Conversations On Reproductive Health - Episode 1

November 15th 2023
Podcast
Tucatinib, Trastuzumab Combination Improves Progression-Free Survival in HER2+, Locally Advanced or Metastatic Breast Cancer

Tucatinib, Trastuzumab Combination Improves Progression-Free Survival in HER2+, Locally Advanced or Metastatic Breast Cancer

December 7th 2023
Article
Adding Pembrolizumab to Chemotherapy Increased Pathological Complete Response, Improved Residual Cancer Burden in Early-Stage, High-Risk ER+/HER2- Breast Cancer

Adding Pembrolizumab to Chemotherapy Increased Pathological Complete Response, Improved Residual Cancer Burden in Early-Stage, High-Risk ER+/HER2- Breast Cancer

December 7th 2023
Article
© 2023 MJH Life Sciences

All rights reserved.